JPH0819071B2 - 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same - Google Patents

3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same

Info

Publication number
JPH0819071B2
JPH0819071B2 JP63206940A JP20694088A JPH0819071B2 JP H0819071 B2 JPH0819071 B2 JP H0819071B2 JP 63206940 A JP63206940 A JP 63206940A JP 20694088 A JP20694088 A JP 20694088A JP H0819071 B2 JPH0819071 B2 JP H0819071B2
Authority
JP
Japan
Prior art keywords
group
amino
carbon atoms
linear
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63206940A
Other languages
Japanese (ja)
Other versions
JPH0256457A (en
Inventor
孜郎 寺島
冬彦 松田
光代 松本
正子 大崎
芳雄 伊藤
邦和 酒井
大英 常本
哲聖 上條
弘 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Sagami Chemical Research Institute (Sagami CRI)
Original Assignee
Kissei Pharmaceutical Co Ltd
Sagami Chemical Research Institute (Sagami CRI)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Sagami Chemical Research Institute (Sagami CRI) filed Critical Kissei Pharmaceutical Co Ltd
Priority to JP63206940A priority Critical patent/JPH0819071B2/en
Publication of JPH0256457A publication Critical patent/JPH0256457A/en
Publication of JPH0819071B2 publication Critical patent/JPH0819071B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、一般式 (式中、R1は炭素数1〜4の直鎖若しくは分枝アルキル
基、炭素数5〜8のシクロアルキル基を表し、R2は炭素
数1〜4の直鎖あるいは分枝アルカノイル基、塩素原子
若しくはメトキシ基で置換されていてもよいアロイル
基、炭素数1〜5の直鎖あるいは分枝アルコキシカルボ
ニル基、または塩素原子若しくはメトキシ基で置換され
ていてもよいアラルコキシカルボニル基を表し、R3は水
素原子、炭素数1〜4の直鎖若しくは分枝アルキル基ま
たは塩素原子若しくはメトキシ基で置換されていてもよ
いアリール基を表す)で表される3−アミノ−2−アシ
ルオキシ−ブチロニトリル誘導体およびその製造方法に
関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] (In the formula, R 1 represents a linear or branched alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, R 2 represents a linear or branched alkanoyl group having 1 to 4 carbon atoms, Represents an aroyl group optionally substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms, or an aralkoxycarbonyl group optionally substituted with a chlorine atom or a methoxy group. , R 3 represents a hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms, or a chlorine atom or an aryl group which may be substituted with a methoxy group). The present invention relates to a butyronitrile derivative and a method for producing the same.

本発明の一般式(I)で表される3−アミノ−2−ア
シルオキシ−ブチロニトリル誘導体は、医薬品の合成原
料としての用途を有する。例えば、一般式(I)におい
て、R1がシクロヘキシル基、2位不斉炭素が(R)−配
置および3位不斉炭素が(S)−配置である化合物は、
ヒトレニン阻害作用により高血圧症治療剤として有用な
アミノ酸誘導体の製造中間体である光学活性(2R,3S)
−3−アミノ−4−シクロヘキシル−2−ヒドロキシ酪
酸の合成原料として使用できる(特開昭62-234071、日
本薬学会第108年会講演要旨集39ページ、(1988年)お
よび参考例参照)。
The 3-amino-2-acyloxy-butyronitrile derivative represented by the general formula (I) of the present invention has use as a synthetic raw material for pharmaceuticals. For example, in the general formula (I), a compound in which R 1 is a cyclohexyl group, a 2-position asymmetric carbon is (R) -configuration and a 3-position asymmetric carbon is (S) -configuration is
Optical activity (2R, 3S), which is an intermediate for the production of amino acid derivatives useful as therapeutic agents for hypertension due to human renin inhibitory action
It can be used as a starting material for the synthesis of -3-amino-4-cyclohexyl-2-hydroxybutyric acid (see JP-A-62-234071, Japanese Pharmacy Society 108th Annual Meeting Abstracts, page 39, (1988) and Reference Examples).

〔従来の技術〕[Conventional technology]

有用な医薬品の製造中間体である光学活性(2R,3S)
−3−アシル−4−シクロヘキシル−2−ヒドロキシ酪
酸は、一般式 (式中、R1およびR2は前記と同じ意味を表す)で表され
るアルデヒド誘導体、あるいはその亜硫酸ナトリウム付
加物、シアン化ナトリウム、シアン化カリウムなどの青
酸塩を希塩酸存在下、あるいはシアン化ナトリウム、シ
アン化カリウムなどの青酸塩を直接反応させることによ
って得られる、一般式 (式中、R1およびR2は前記と同じ意味を表す)で表され
る3−アミノ−2−ヒドロキシ−ブチロニトリル誘導体
を酸性条件下加水分解することによって専ら得られてい
た(特開昭62-234071参照)。
Optical activity (2R, 3S), which is a useful intermediate for the production of pharmaceuticals
-3-Acyl-4-cyclohexyl-2-hydroxybutyric acid has the general formula (In the formula, R 1 and R 2 have the same meanings as described above), an aldehyde derivative represented by the above, or a sodium sulfite adduct thereof, sodium cyanide, potassium cyanide, or another cyanide salt in the presence of dilute hydrochloric acid, or sodium cyanide, A general formula obtained by directly reacting a cyanide salt such as potassium cyanide It was obtained exclusively by hydrolyzing a 3-amino-2-hydroxy-butyronitrile derivative represented by the formula (wherein R 1 and R 2 have the same meanings as described above) under acidic conditions (JP-A-62-62). -234071).

本製造工程において、(S)−配置を有する一般式
(II)で表されるアルデヒド誘導体を用いた場合、一般
式(III)で表される3−アミノ−2−ヒドロキシ−ブ
チロニトリル誘導体は2位の不斉炭素に関して(R)−
配置と(S)−配置を有する2種のジアステレオマーの
混合物として得られるがその立体選択性は従来大変低い
ものであった(特開昭62-33141参照)。
In the production process, when the aldehyde derivative represented by the general formula (II) having the (S) -configuration is used, the 3-amino-2-hydroxy-butyronitrile derivative represented by the general formula (III) is at the 2-position. The asymmetric carbon of (R)-
It is obtained as a mixture of two diastereomers having the configuration and the (S) -configuration, but its stereoselectivity has hitherto been very low (see JP-A-62-33141).

この様な低い立体選択性で得られた一般式(III)で
表される3−アミノ−2−ヒドロキシ−ブチロニトリル
誘導体の分離は大変煩雑であり(特開昭62-33141参
照)、また、このものを酸性条件下加水分解した場合、
得られる3−アミノ−2−ヒドロキシ酪酸誘導体も立体
選択性が低い2種のジアステレオマーの混合物となり、
このものから所望の(2R,3S)−3−アミノ−2−ヒド
ロキシ酪酸誘導体を分離することも多大の困難を伴って
いた(特開昭62-234071参照)。
Separation of the 3-amino-2-hydroxy-butyronitrile derivative represented by the general formula (III) obtained with such low stereoselectivity is very complicated (see JP-A-62-33141). When something is hydrolyzed under acidic conditions,
The resulting 3-amino-2-hydroxybutyric acid derivative also becomes a mixture of two diastereomers with low stereoselectivity,
Separation of the desired (2R, 3S) -3-amino-2-hydroxybutyric acid derivative from this was also accompanied by great difficulty (see JP-A-62-234071).

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明者らは、医薬品製造中間体である3−アミノ−
2−ヒドロキシ酪酸誘導体を一般式(II)で表されるア
ルデヒド誘導体から高立体選択的に製造する方法、すな
わち、(S)−配置を有する一般式(II)で表されるア
ルデヒド誘導体から(2R,3S)−3−アミノ−2−ヒド
ロキシ酪酸誘導体を高立体選択的に製造する方法を探索
した結果、本発明の化合物およびその製造方法を見出
し、本発明を完成した。
The present inventors have found that 3-amino-
A method for producing a 2-hydroxybutyric acid derivative from an aldehyde derivative represented by the general formula (II) in a highly stereoselective manner, that is, from an aldehyde derivative represented by the general formula (II) having a (S) -configuration (2R As a result of searching for a method for producing a (3,3S) -3-amino-2-hydroxybutyric acid derivative with high stereoselectivity, the compound of the present invention and a method for producing the same were found, and the present invention was completed.

〔問題点を解決するための手段〕[Means for solving problems]

前記一般式(I)で表される新規な3−アミノ−2−
アシルオキシ−ブチロニトリル誘導体は下記の反応式に
従い製造できる。
Novel 3-amino-2-represented by the general formula (I)
The acyloxy-butyronitrile derivative can be produced according to the following reaction formula.

(式中、R1、R2、R3は前記と同じ意味を表し、R5は炭素
数1〜4の直鎖または分枝低級アルキル基を表す) (第1工程) 本工程は、一般式(IV)で表される2−アミノ−プロ
ピオン酸エステル誘導体にアミノ基の保護基を導入後エ
ステル基を還元し、さらに必要に応じて3位フェニル基
などの還元を行い、一般式(V)で表される2−アミノ
−プロパノール誘導体を製造するものである(参考例参
照)。
(In the formula, R 1 , R 2 , and R 3 have the same meanings as described above, and R 5 represents a linear or branched lower alkyl group having 1 to 4 carbon atoms.) (First Step) This step is generally After introducing a protecting group for an amino group into the 2-amino-propionic acid ester derivative represented by the formula (IV), the ester group is reduced, and further, if necessary, the 3-position phenyl group or the like is reduced to give ) To produce a 2-amino-propanol derivative (see Reference Example).

2−アミノ−プロピオン酸エステル塩酸塩としては、
2−アミノ−プロピオン酸メチル塩酸塩、2−アミノ−
プロピオン酸エチル塩酸塩、2−アミノ−プロピオン酸
イソプロピル塩酸塩などが例示でき、これらのものは公
知の方法によって製造できる(Chem.Pharm.Bull.,13,99
5(1965).,およびS.R.Sandler and W.Karo,“Function
al Group Preparations",Academic Press,New York,196
8,pp245〜265.参照)。
As 2-amino-propionic acid ester hydrochloride,
2-Amino-methyl propionate hydrochloride, 2-amino-
Examples include ethyl propionate hydrochloride, isopropyl 2-amino-propionate hydrochloride, and these can be produced by known methods (Chem.Pharm.Bull., 13 , 99).
5 (1965)., And SR Sandler and W. Karo, “Function
al Group Preparations ", Academic Press, New York, 196
8, pp245-265.).

2−アミノ−プロピオン酸エステル塩酸塩に導入され
るアミノ基の保護基としては、酸性条件下加水分解する
ことによって除去できるものならばいかなるものも使用
できるが、好適にはホルミル基、アセチル基、プロピオ
ニル基、ブチリル基、イソブチリル基などの炭素数1〜
4の直鎖あるいは分枝アルカノイル基、ベンゾイル基、
p−クロロベンゾイル基、p−メトキシベンゾイル基な
どの無置換あるいは置換アロイル基、メトキシカルボニ
ル基、エトキシカルボニル基、イソプロポキシカルボニ
ル基、t−ブチルオキシカルボニル基などの炭素数1〜
5の直鎖あるいは分枝アルコキシカルボニル基、ベンジ
ルオキシカルボニル基、p−クロロベンジルオキシカル
ボニル基、p−メトキシベンジルオキシカルボニル基な
どの無置換あるいは置換アラルコキシカルボニル基が用
いられる。これらの保護基は公知の方法によって導入で
きる(T.W.Greene,“Protective Groups in Organic Sy
nthesis",John-Wiley&Sons,New York,1980,pp218〜28
7.参照)。
As the amino group-protecting group introduced into 2-amino-propionate hydrochloride, any group can be used as long as it can be removed by hydrolysis under acidic conditions, but preferably a formyl group, an acetyl group, 1 to 1 carbon atoms such as propionyl group, butyryl group, isobutyryl group
4 straight or branched alkanoyl group, benzoyl group,
Unsubstituted or substituted aroyl group such as p-chlorobenzoyl group and p-methoxybenzoyl group, methoxycarbonyl group, ethoxycarbonyl group, isopropoxycarbonyl group, t-butyloxycarbonyl group and the like having 1 to 1 carbon atoms
An unsubstituted or substituted aralkoxycarbonyl group such as a straight chain or branched alkoxycarbonyl group of 5, a benzyloxycarbonyl group, a p-chlorobenzyloxycarbonyl group and a p-methoxybenzyloxycarbonyl group is used. These protecting groups can be introduced by a known method (TW Greene, “Protective Groups in Organic Sy
nthesis ", John-Wiley & Sons, New York, 1980, pp218-28
7.).

アミノ基が保護された2−アミノ−プロピオン酸エス
テルのエステル基の還元は、適当な還元剤、例えば、塩
化リチウムまたは臭化リチウム存在下水素化ホウ素ナト
リウムを用いて行われる(参考例参照)。
The reduction of the ester group of the amino group-protected 2-amino-propionic acid ester is carried out using an appropriate reducing agent, for example, sodium borohydride in the presence of lithium chloride or lithium bromide (see Reference Example).

また一般式(V)で表される2−アミノ−プロパノー
ル誘導体の3位にフェニル基が存在する場合、適当な触
媒、例えば、5%ロジウム−アルミナの存在下に水添し
て3位にシクロヘキシル基を有する2−アミノ−プロパ
ノール誘導体を得ることもできる(参考例参照)。
When the 2-amino-propanol derivative represented by the general formula (V) has a phenyl group at the 3-position, it is hydrogenated in the presence of a suitable catalyst, for example, 5% rhodium-alumina to give cyclohexyl at the 3-position. It is also possible to obtain a 2-amino-propanol derivative having a group (see Reference Example).

本工程において、(S)−配置を有する一般式(IV)
で表される2−アミノ−プロピオン酸エステル塩酸塩を
用いた場合には、(S)−配置を有する一般式(V)で
表される2−アミノ−プロパノール誘導体がラセミ化す
ることなく得られる。
In this step, in the general formula (IV) having the (S) -configuration,
When the 2-amino-propionic acid ester hydrochloride represented by is used, the 2-amino-propanol derivative represented by the general formula (V) having the (S) -configuration is obtained without racemization. .

(第2工程) 本工程は一般式(V)で表される2−アミノ−プロパ
ノール誘導体を酸化し、一般式(II)で表される2−ア
ミノ−プロパナール誘導体を製造するものである。好適
は酸化方法としては、ジメチルスルホキシド中三酸化イ
オウ−ピリジン錯体−トリエチルアミンを用いる方法が
例示できる(参考例参照)。
(Second Step) In this step, the 2-amino-propanol derivative represented by the general formula (V) is oxidized to produce the 2-amino-propanal derivative represented by the general formula (II). As a preferable oxidation method, a method using sulfur trioxide in dimethyl sulfoxide-pyridine complex-triethylamine can be exemplified (see Reference Example).

本工程において、(S)−配置を有する一般式(V)
で表される2−アミノ−プロパノール誘導体を用いた場
合には、(S)−配置を有する一般式(II)で表される
2−アミノ−プロパナール誘導体がラセミ化することな
く得られる。
In this step, the general formula (V) having the (S) -configuration is shown.
When the 2-amino-propanol derivative represented by is used, the 2-amino-propanal derivative represented by the general formula (II) having the (S) -configuration is obtained without racemization.

(第3工程) 本工程は一般式(II)で表される2−アミノ−プロパ
ナール誘導体を、一般式 R3COOCOR4 (VI) (式中、R3、R4は、各々独立に、水素原子、炭素数1〜
4の直鎖若しくは分枝アルキル基または塩素原子若しく
はメトキシ基で置換されていてもよいアリール基を表
す)で表されるカルボン酸無水物および青酸塩と、第四
級アンモニウム塩、第三級アミン、または第四級アンモ
ニウム塩および第三級アミンの存在下反応させることに
より、本発明の化合物である一般式(I)で表される3
−アミノ−2−アシルオキシ−ブチロニトロリル誘導体
を製造するものである。
(Third Step) In this step, the 2-amino-propanal derivative represented by the general formula (II) is represented by the general formula R 3 COOCOR 4 (VI) (wherein R 3 and R 4 are each independently, Hydrogen atom, carbon number 1
4 represents a linear or branched alkyl group of 4 or an aryl group which may be substituted with a chlorine atom or a methoxy group) and a carboxylic acid anhydride, and a quaternary ammonium salt, a quaternary ammonium salt, and a tertiary amine. , Or a quaternary ammonium salt and a tertiary amine in the presence of the compound of the general formula (I)
To produce an amino-2-acyloxy-butyronitrolyl derivative.

一般式(VI)で表されるカルボン酸無水物としては、
ギ酸酢酸無水物、無水酢酸、無水プロピオン酸、無水イ
ソ酪酸、無水安息香酸、無水p−クロロ安息香酸、無水
p−メトキシ安息香酸などが例示できるが、好適には無
水酢酸あるいは無水安息香酸が用いられる。用いられる
カルボン酸無水物は2−アミノ−プロパナール誘導体に
対して、1.0〜20当量用いられるが、2.5〜7.0当量用い
た場合に好ましい結果が得られる。第四級アンモニウム
塩としては、塩化テトラブチルアンモニウム、臭化テト
ラブチルアンモニウム、塩化ベンジルトリメチルアンモ
ニウム、臭化ベンジルトリメチルアンモニウム、塩化ベ
ンジルトリエチルアンモニウム、塩化ベンジルトリブチ
ルアンモニウム、臭化ベンジルトリブチルアンモニウ
ム、塩化メチルトリオクチルアンモニウム、塩化N−ベ
ンジルキニジニウム、塩化N−ベンジルキニニウム、塩
化N−ベンジルシンコニジニウム、塩化N−ベンジルシ
ンコニニウム、塩化N−ベンジル−N−メチルエフェド
リニウムなどが例示される。第四級アンモニウム塩は、
2−アミノ−プロパナール誘導体に対して0.005〜0.20
当量用いられるが0.01〜0.07当量用いた場合に好ましい
結果が得られる。第三級アミンとしては、トリメチルア
ミン、トリエチルアミン、エチルジイソプロピルアミ
ン、トリブチルアミン、N,N−テトラメチルエチレンジ
アミン、N−メチルピロリジン、N−エチルピロリジ
ン、N−ベンジルピロリジン、N−メチルモルホリン、
N−エチルモルホリン、N−ベンジルモルホリン、1,4
−ジアザビシクロ〔2,2,2〕オクタン、1,5−ジアザビシ
クロ〔4,3,0〕ノン−5−エン、1,8−ジアザビシクロ
〔5,4,0〕ウンデク−7−エン、ピリジン、2−メチル
ピリジン、2,4,5−トリメチルピリジン、4−ジメチル
アミノピリジン、キノリンなどが例示できるが、好適に
は、ピリジン、4−ジメチルアミノピリジンが用いられ
る。第三級アミンは2−アミノ−プロパナール誘導体に
対して0.001〜0.10当量用いられるが、好適には0.005〜
0.02当量用いられる。
As the carboxylic acid anhydride represented by the general formula (VI),
Formic acid acetic anhydride, acetic anhydride, propionic anhydride, isobutyric anhydride, benzoic anhydride, p-chlorobenzoic anhydride, p-methoxybenzoic anhydride and the like can be exemplified, but acetic anhydride or benzoic anhydride is preferably used. To be The carboxylic acid anhydride used is used in an amount of 1.0 to 20 equivalents based on the 2-amino-propanal derivative, but preferable results are obtained when used in 2.5 to 7.0 equivalents. Examples of the quaternary ammonium salt include tetrabutylammonium chloride, tetrabutylammonium bromide, benzyltrimethylammonium chloride, benzyltrimethylammonium bromide, benzyltriethylammonium chloride, benzyltributylammonium chloride, benzyltributylammonium bromide and methyltrioctyl chloride. Examples include ammonium, N-benzylquinidinium chloride, N-benzylquininium chloride, N-benzylcinchonidinium chloride, N-benzylcinchoninium chloride, N-benzyl-N-methylephedrinium chloride and the like. The quaternary ammonium salt is
0.005-0.20 relative to 2-amino-propanal derivative
It is used in equivalent amounts, but preferable results are obtained when 0.01 to 0.07 equivalents are used. As the tertiary amine, trimethylamine, triethylamine, ethyldiisopropylamine, tributylamine, N, N-tetramethylethylenediamine, N-methylpyrrolidine, N-ethylpyrrolidine, N-benzylpyrrolidine, N-methylmorpholine,
N-ethylmorpholine, N-benzylmorpholine, 1,4
-Diazabicyclo [2,2,2] octane, 1,5-diazabicyclo [4,3,0] non-5-ene, 1,8-diazabicyclo [5,4,0] undec-7-ene, pyridine, 2 -Methylpyridine, 2,4,5-trimethylpyridine, 4-dimethylaminopyridine, quinoline and the like can be exemplified, but pyridine and 4-dimethylaminopyridine are preferably used. The tertiary amine is used in an amount of 0.001 to 0.10 equivalent to the 2-amino-propanal derivative, preferably 0.005 to
Used in 0.02 equivalents.

本反応に用いられる青酸塩としてはシアン化ナトリウ
ム、シアン化カリウムなどのアルカリ金属青酸塩が例示
できる。青酸塩は2−アミノ−プロパナール誘導体に対
して1.0〜10当量用いられるが、1.5〜6.0当量用いた場
合に好ましい結果が得られる。
Examples of the cyanide salt used in this reaction include alkali metal cyanide salts such as sodium cyanide and potassium cyanide. The hydrocyanic acid salt is used in an amount of 1.0 to 10 equivalents relative to the 2-amino-propanal derivative, but favorable results are obtained when used in an amount of 1.5 to 6.0 equivalents.

本反応は有機溶媒中で行われ、より好ましくは水と有
機溶媒の二層系で行われる。用いられる有機溶媒として
は、ジクロロメタン、クロロホルム、四塩化炭素、1,2
−ジクロロエタン、1,1,1−トリクロロエタンなどのハ
ロゲン化炭化水素系溶媒、酢酸エチル、酢酸イソアミル
などの酢酸エステル類、トルエン、キシレンなどの炭化
水素系溶媒など水と混合しないものが例示できるが、好
適にはジクロロメタン、クロロホルム、1,2−ジクロロ
エタンが用いられる。水と有機溶媒との二層系で反応を
行う場合、その組成比は特に限定されないが、1:1の組
成比の場合に最も好ましい結果を与える。
This reaction is carried out in an organic solvent, more preferably a two-layer system of water and an organic solvent. The organic solvent used is dichloromethane, chloroform, carbon tetrachloride, 1,2
-Dichloroethane, halogenated hydrocarbon solvents such as 1,1,1-trichloroethane, ethyl acetate, acetic acid esters such as isoamyl acetate, toluene, hydrocarbon solvents such as xylene, which are immiscible with water, can be exemplified. Dichloromethane, chloroform and 1,2-dichloroethane are preferably used. When the reaction is carried out in a two-layer system of water and an organic solvent, the composition ratio is not particularly limited, but a composition ratio of 1: 1 gives the most preferable result.

本反応は−10〜50℃で行われるが、水と有機溶媒との
二層系で反応を行う場合、0〜5℃で最も好ましい結果
が得られる。
This reaction is carried out at -10 to 50 ° C, but when the reaction is carried out in a two-layer system of water and an organic solvent, the most preferable result is obtained at 0 to 5 ° C.

本反応において(S)−配置を有する2−アミノ−プ
ロパナール誘導体を用いた場合、(2R,3S)−配置を有
する3−アミノ−2−アシルオキシ−ブチロニトリル誘
導体が、(2S,3S)−配置を有する3−アミノ−2−ア
シルオキシ−ブチロニトリル誘導体に対して高選択的
(最大7:1)に生成する。
When a 2-amino-propanal derivative having a (S) -configuration is used in this reaction, a 3-amino-2-acyloxy-butyronitrile derivative having a (2R, 3S) -configuration is converted into a (2S, 3S) -configuration. It is highly selective (up to 7: 1) for 3-amino-2-acyloxy-butyronitrile derivatives having

本反応をカルボン酸無水物の存在しない状態で行った
場合には、(S)−配置を有する2−アミノ−プロパナ
ール誘導体から一般式(III)で表される3−アミノ−
2−ヒドロキシ−ブチロニトリル誘導体が2種のジアス
テレオマーの等量混合物として得られる(比較例1およ
び2参照)。
When this reaction is carried out in the absence of carboxylic acid anhydride, a 2-amino-propanal derivative having a (S) -configuration is used to form 3-amino-of the formula (III).
The 2-hydroxy-butyronitrile derivative is obtained as an equal mixture of two diastereomers (see Comparative Examples 1 and 2).

上記の合成工程によって得られた一般式(I)で表さ
れる3−アミノ−2−アシルオキシ−ブチロニトリル誘
導体を、酸性条件下、加水分解反応に付することにより
ニトリル基の加水分解と同時に3位アミノ基と2位水酸
基の脱保護を同時に行い、一般式 (式中、R1は前記と同じ意味を表す)で表される医薬品
合成中間体として有用な3−アミノ−2−ヒドロキシ酪
酸塩酸塩が得られた。本加水分解反応を(2R,3S)−3
−アミノ−2−アシルオキシ−4−シクロヘキシル−ブ
チロニトリルをその(2S,3S)−体に対して7:1の比率で
含有するサンプルについて行った場合には、ヒトレニン
阻害作用により高血圧症の治療剤として有用なアミノ酸
誘導体の製造中間体として用いられる光学活性(2R,3
S)−3−アミノ−4−シクロヘキシル−2−ヒドロキ
シ酪酸塩酸塩が高立体選択的に得られた。
The 3-amino-2-acyloxy-butyronitrile derivative represented by the general formula (I) obtained by the above synthesis step is subjected to a hydrolysis reaction under acidic conditions to simultaneously hydrolyze the nitrile group and the 3-position. Deprotection of amino group and 2-position hydroxyl group at the same time 3-amino-2-hydroxybutyric acid hydrochloride useful as a pharmaceutical synthesis intermediate represented by the formula (wherein R 1 has the same meaning as described above) was obtained. This hydrolysis reaction is (2R, 3S) -3
When a sample containing -amino-2-acyloxy-4-cyclohexyl-butyronitrile in a ratio of 7: 1 to its (2S, 3S) -form was used, it was treated as a therapeutic agent for hypertension due to its human renin inhibitory effect. Optical activity used as an intermediate for the production of useful amino acid derivatives (2R, 3
S) -3-Amino-4-cyclohexyl-2-hydroxybutyric acid hydrochloride was obtained highly stereoselectively.

以下、本発明の内容を実施例、参考例、比較例を用い
て詳細に説明するが、本発明はこれらによって何ら限定
されるものではない。
Hereinafter, the content of the present invention will be described in detail with reference to Examples, Reference Examples and Comparative Examples, but the present invention is not limited to these.

参考例1 (s)−フェニルアラニンメチルエステル塩酸塩20.0
g(93mmol)を無水テトラヒドロフラン100mlに懸濁し、
氷冷下トリエチルアミン27.1ml(194mmol)とクロロ炭
酸イソプロピル12.5ml(110mmol)を同時に30分間で滴
下した。氷冷下1時間攪拌後、減圧下に濃縮した。残渣
に酢酸エチルを加え、1M塩酸、飽和食塩水、飽和重曹
水、および飽和食塩水で順次洗浄した。無水硫酸マグネ
シウムで乾燥後、減圧下に濃縮し、白色固体のN−(イ
ソプロポキシカルボニル)−(S)−フェニルアラニン
メチルエステル24.0g(98%)を得た。
Reference Example 1 (s) -Phenylalanine methyl ester hydrochloride 20.0
g (93 mmol) was suspended in 100 ml of anhydrous tetrahydrofuran,
Under ice cooling, 27.1 ml (194 mmol) of triethylamine and 12.5 ml (110 mmol) of isopropyl chlorocarbonate were simultaneously added dropwise over 30 minutes. After stirring for 1 hour under ice cooling, the mixture was concentrated under reduced pressure. Ethyl acetate was added to the residue, and the mixture was washed successively with 1M hydrochloric acid, saturated brine, saturated aqueous sodium hydrogen carbonate, and saturated brine. After drying over anhydrous magnesium sulfate, the mixture was concentrated under reduced pressure to obtain 24.0 g (98%) of N- (isopropoxycarbonyl)-(S) -phenylalanine methyl ester as a white solid.

融 点:32〜34℃ Rf:0.76(クロロホルム/メタノール=30/1) IR(KBr):1735,1680cm-1 NMR(CDCl3) δ:1.21(6H,d,J=6Hz),3.11(2H,d,J=6Hz),3.72(3
H,s),4.50〜5.20(2H,m),4.92(1H,quintet,J=6H
z),7.04〜7.48(5H,m) 参考例2 N−(イソプロポキシカルボニル)−(S)−フェニ
ルアラニンメチルエステル12.0g(45mmol)を無水テト
ラヒドロフラン145mlに溶解し、臭化リチウム1水和物
9.48g(90mmol)、水素化ホウ素ナトリウム3.42g(90mm
ol)を加え、室温で一晩攪拌した。反応液を減圧下に濃
縮後、攪拌下1M塩酸を加え(pH2〜3)析出結晶をろ取
した。水洗後減圧下に乾燥し、白色結晶のN−(イソプ
ロポキシカルボニル)−(S)−フェニルアラニノール
11.1gを定量的に得た。
Melting point: 32-34 ° C Rf: 0.76 (chloroform / methanol = 30/1) IR (KBr): 1735, 1680cm -1 NMR (CDCl 3 ) δ: 1.21 (6H, d, J = 6Hz), 3.11 (2H , d, J = 6Hz), 3.72 (3
H, s), 4.50-5.20 (2H, m), 4.92 (1H, quintet, J = 6H
z), 7.04 to 7.48 (5H, m) Reference Example 2 12.0 g (45 mmol) of N- (isopropoxycarbonyl)-(S) -phenylalanine methyl ester was dissolved in 145 ml of anhydrous tetrahydrofuran to prepare lithium bromide monohydrate.
9.48g (90mmol), sodium borohydride 3.42g (90mm
ol) was added and the mixture was stirred at room temperature overnight. The reaction mixture was concentrated under reduced pressure, 1M hydrochloric acid was added with stirring (pH 2-3), and the precipitated crystals were collected by filtration. After washing with water and drying under reduced pressure, white crystals of N- (isopropoxycarbonyl)-(S) -phenylalaninol
11.1 g was quantitatively obtained.

融 点:77〜79℃ Rf:0.72(クロロホルム/メタノール=5/1) IR(KBr):1680cm-1 NMR(CDCl3) δ:1.21(6H,d,J=6Hz),1.96〜2.30(1H,m),2.88(2
H,d,J=7Hz),3.44〜4.16(3H,m),4.65-5.13(1H,m),
4.92(1H,quintet,J=6Hz),7.05〜7.47(5H,m) 参考例3 N−(イソプロポキシカルボニル)−(S)−フェニ
ルアラニノール1.0g(4.2mmol)と5%ロジウム−アル
ミナ50mgにメタノール1.5mlを加え、25℃で水素圧(4kg
/cm2〜3kg/cm2)で攪拌する。残渣にベンゼンを加え、
さらに減圧濃縮し、無色粘性オイル状のN−(イソプロ
ポキシカルボニル−(S)−シクロヘキシルアラニノー
ル0.98g(96%)を得た。
Melting point: 77 to 79 ° C Rf: 0.72 (chloroform / methanol = 5/1) IR (KBr): 1680cm -1 NMR (CDCl 3 ) δ: 1.21 (6H, d, J = 6Hz), 1.96 to 2.30 (1H , m), 2.88 (2
H, d, J = 7Hz), 3.44-4.16 (3H, m), 4.65-5.13 (1H, m),
4.92 (1H, quintet, J = 6Hz), 7.05 to 7.47 (5H, m) Reference Example 3 N- (isopropoxycarbonyl)-(S) -phenylalaninol 1.0g (4.2mmol) and 5% rhodium-alumina 50mg 1.5 ml of methanol was added to, and hydrogen pressure (4 kg
/ cm 2 to 3 kg / cm 2 ). Add benzene to the residue,
Further, it was concentrated under reduced pressure to obtain 0.98 g (96%) of N- (isopropoxycarbonyl- (S) -cyclohexylalaninol as a colorless viscous oil.

Rf:0.76(クロロホルム/メタノール=5/1) IR(neat):1680cm-1 NMR(CDCl3) δ:1.23(6H,d,J=6Hz),0.71〜2.13(13H,m),3.36〜
4.02(3H,m),4.51〜5.15(1H,m),4.93(1H,quintet,J
=6Hz) 参考例4 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール505mg(2.1mmol)、トルエン1.30
ml、ジメチルスルホキシド2.55ml(36mmol)およびトリ
エチルアミン1.45ml(10mmol)の混合物に三酸化イオウ
−ピリジン錯塩1.66g(10mmol)を加え、室温で1時間
攪拌した。反応液に氷水を加え、トルエンで抽出し、抽
出液を水、飽和重曹水、飽和食塩水で順次洗浄した。無
水硫酸ナトリウム上で乾燥後、減圧下に濃縮し、淡黄色
オイル状のN−(イソプロポキシカルボニル)−(S)
−シクロヘキシルアラニナール367mg(73%)を得た。
このものは精製することなく次の3−アミノ−2−アシ
ルオキシブチロチトリル誘導体の製造に供した。
Rf: 0.76 (chloroform / methanol = 5/1) IR (neat ): 1680cm -1 NMR (CDCl 3) δ: 1.23 (6H, d, J = 6Hz), 0.71~2.13 (13H, m), 3.36~
4.02 (3H, m), 4.51 ~ 5.15 (1H, m), 4.93 (1H, quintet, J
= 6 Hz) Reference Example 4 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol 505 mg (2.1 mmol), toluene 1.30
ml, dimethyl sulfoxide 2.55 ml (36 mmol) and triethylamine 1.45 ml (10 mmol) were added with sulfur trioxide-pyridine complex salt 1.66 g (10 mmol), and the mixture was stirred at room temperature for 1 hour. Ice water was added to the reaction solution, and the mixture was extracted with toluene, and the extract was washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. After drying over anhydrous sodium sulfate, it was concentrated under reduced pressure to give N- (isopropoxycarbonyl)-(S) as a pale yellow oil.
367 mg (73%) of cyclohexylalaninal was obtained.
This product was used for the next production of the 3-amino-2-acyloxybutyrotitril derivative without purification.

Rf:0.40(ヘキサン/酢酸エチル=7/3) NMR(CDCl3) δ:0.64〜1.94(13H,m),1.23(6H,d,J=7Hz),4.13〜
4.45(1H,m),4.77〜5.25(2H,m),9.61(1H,s) 実施例1 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.0mg(0.10mmol)を塩化メチレン1.5m
lに溶解し、無水酢酸0.035ml(0.37mmol)、塩化ベンジ
ルトリブチルアンモニウム1.9mg(0.006mmol)、0.25M
シアン化ナトリウム水溶液1.5ml(0.38mmol)を氷冷下
順次加え、同温度で1.5時間攪拌した。反応液に50%飽
和食塩水を加え、塩化メチレンで抽出し、抽出液を水、
飽和食塩水で順次洗浄した。無水硫酸ナトリウム上で乾
燥後、減圧下に濃縮し、残渣をカラムクロマトグラフィ
ー(シリカゲル、ヘキサン−酢酸エチル30:1→10:1)で
精製し、無色オイル状の(2R,3S)−2−アセトキシ−
4−シクロヘキシル−3−イソプロポキシカルボニルア
ミノブチロニトリルおよびその(2S,3S)−体との混合
物15.7mg(41%:N−(イソプロポキシカルボニル)−
(S)−シクロヘキシルアラニノールからの通算収率)
を得た。(2R,3S)−体と(2S,3S)−体との生成比はNM
Rスペクトル(400MHz)から6:1と決定した。
Rf: 0.40 (hexane / ethyl acetate = 7/3) NMR (CDCl 3 ) δ: 0.64 to 1.94 (13H, m), 1.23 (6H, d, J = 7Hz), 4.13 to
4.45 (1H, m), 4.77 to 5.25 (2H, m), 9.61 (1H, s) Example 1 N-obtained from 30.0 mg (0.12 mmol) of N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol −
(Isopropoxycarbonyl)-(S) -cyclohexylalaninal 25.0 mg (0.10 mmol) was added to methylene chloride 1.5 m.
Dissolve in l, acetic anhydride 0.035ml (0.37mmol), benzyltributylammonium chloride 1.9mg (0.006mmol), 0.25M
1.5 ml (0.38 mmol) of an aqueous solution of sodium cyanide was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 1.5 hours. 50% saturated saline solution was added to the reaction solution, and extracted with methylene chloride.
It was washed successively with saturated saline. After drying over anhydrous sodium sulfate, the mixture was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, hexane-ethyl acetate 30: 1 → 10: 1) to give a colorless oily (2R, 3S) -2- Acetoxy
4-Cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its mixture with (2S, 3S) -form 15.7 mg (41%: N- (isopropoxycarbonyl)-
(Total yield from (S) -cyclohexylalaninol)
I got The production ratio of (2R, 3S) -body and (2S, 3S) -body is NM
It was determined to be 6: 1 from the R spectrum (400 MHz).

Rf:0.54(ヘキサン/酢酸エチル=7/3) IR(nujol):1755,1690cm-1 NMR(CDCl3) (2R,3S)−体;δ0.81〜1.90(13H,m),1.25(6H,d,J
=6.1Hz),2.16(3H,s),4.00〜4.28(1H,m),4.37〜4.
73(1H,m),4.83〜5.08(1H,m),5.40(1H,d,J=4.5H
z) (2S,3S)−体;δ0.81〜1.90(13H,m),1.25(6H,d,J
=6.1Hz),2.14(3H,s),4.00〜4.28(1H,m),4.37〜4.
73(1H,m),4.83〜5.08(1H,m),5.43(1H,d,J=3.5H
z) MS(m/e):311(〔M+1〕+),251,212 実施例2 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.3mg(0.10mmol)を塩化メチレン1.5m
lに溶解し、無水酢酸0.035ml(0.37mmol)、4−ジメチ
ルアミノピリジン0.15mg(0.0012mmol)、0.25Mシアン
化ナトリウム水溶液1.5ml(0.38mmol)を水冷下順次加
え、同温度で1.5時間攪拌した。実施例1と同様に処理
し、無色オイル状の(2R,3S)−2−アセトキシ−4−
シクロヘキシル−3−イソプロポキシカルボニルアミノ
ブチロニトリルおよびその(2S,3S)−体との混合物10.
5mg(27%:N−(イソプロポキシカルボニル)−(S)
−シクロヘキシルアラニノールからの通算収率)を得
た。(2R,3S)−体と(2S,3S)−体との生成比は実施例
1と同様にNMRスペクトル(400MHz)から6:1と決定し
た。
Rf: 0.54 (hexane / ethyl acetate = 7/3) IR (nujol): 1755,1690 cm -1 NMR (CDCl 3 ) (2R, 3S) -form; δ0.81 to 1.90 (13H, m), 1.25 (6H , d, J
= 6.1Hz), 2.16 (3H, s), 4.00 to 4.28 (1H, m), 4.37 to 4.
73 (1H, m), 4.83 to 5.08 (1H, m), 5.40 (1H, d, J = 4.5H
z) (2S, 3S) -body; δ 0.81 to 1.90 (13H, m), 1.25 (6H, d, J
= 6.1Hz), 2.14 (3H, s), 4.00 to 4.28 (1H, m), 4.37 to 4.
73 (1H, m), 4.83 to 5.08 (1H, m), 5.43 (1H, d, J = 3.5H
z) MS (m / e): 311 ([M + 1] + ), 251,212 Example 2 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol N-obtained from 30.0 mg (0.12 mmol)
25.3 mg (0.10 mmol) of (isopropoxycarbonyl)-(S) -cyclohexylalaninal was added to 1.5 m of methylene chloride.
Dissolve in l, acetic anhydride 0.035 ml (0.37 mmol), 4-dimethylaminopyridine 0.15 mg (0.0012 mmol), 0.25M sodium cyanide aqueous solution 1.5 ml (0.38 mmol) are sequentially added under water cooling and stirred at the same temperature for 1.5 hours. did. The same treatment as in Example 1 was carried out to give colorless oily (2R, 3S) -2-acetoxy-4-.
Cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its mixture with (2S, 3S) -form 10.
5 mg (27%: N- (isopropoxycarbonyl)-(S)
-Total yield from cyclohexyl alaninol) was obtained. The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was determined to be 6: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例3 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール505mg(2.1mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール367mg(1.5mmol)を塩化メチレン5.0ml
に溶解し、無水酢酸0.60ml(6.4mmol)、4−ジメチル
アミノピリジン2.5mg(0.02mmol)、塩化ベンジルトリ
ブチルアンモニウム32.0mg(0.10mmol)、水3.75ml、5M
シアン化ナトリウム水溶液1.25ml(6.3mmol)を氷冷下
順次加え、同温度で1.5時間攪拌した。実施例1と同様
に処理し、無色オイル状の(2R,3S)−2−アセトキシ
−4−シクロヘキシル−3−イソプロポキシカルボニル
アミノブチロニトリルおよびその(2S,3S)−体との混
合物419mg(65%:N−(イソプロポキシカルボニル)−
(S)−シクロヘキシルアラニノールからの通算収率)
を得た。(2R,3S)−体と(2S,3S)−体との生成比は実
施例1と同様にNMRスペクトル(400MHz)から6:1と決定
した。
Example 3 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol N-obtained from 505 mg (2.1 mmol)
36.7 mg (1.5 mmol) of (isopropoxycarbonyl)-(S) -cyclohexylalaninal was added to 5.0 ml of methylene chloride.
Dissolved in acetic anhydride 0.60 ml (6.4 mmol), 4-dimethylaminopyridine 2.5 mg (0.02 mmol), benzyltributylammonium chloride 32.0 mg (0.10 mmol), water 3.75 ml, 5M
An aqueous solution of sodium cyanide (1.25 ml, 6.3 mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 1.5 hours. Treated as in Example 1, colorless oily mixture of (2R, 3S) -2-acetoxy-4-cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form 419 mg ( 65%: N- (isopropoxycarbonyl)-
(Total yield from (S) -cyclohexylalaninol)
I got The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was determined to be 6: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例4 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール101mg(0.42mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール82.5mg(0.34mmol)を塩化メチレン1.0m
lに溶解し、無水酢酸0.12ml(1.3mmol)、4−ジメチル
アミノピリジン0.5mg(0.004mmol)、塩化N−ベンジル
キニジニウム9.2mg(0.02mmol)、水0.75mlおよび5Mシ
アン化ナトリウム水溶液0.25ml(1.3mmol)を氷冷下順
次加え、同温度で3時間攪拌した。実施例1と同様に処
理し、無色オイル状の(2R,3S)−2−アセトキシ−4
−シクロヘキシル−3−イソプロポキシカルボニルアミ
ノブチロニトリルおよびその(2S,3S)−体との混合物7
4.2mg(57%:N−(イソプロポキシカルボニル)−
(S)−シクロヘキシルアラニノールからの通算収率)
を得た。(2R,3S)−体と(2S,3S)−体との生成比は実
施例1と同様にNMRスペクトル(400MHz)から7:1と決定
した。
Example 4 N- obtained from 101 mg (0.42 mmol) of N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol.
82.5 mg (0.34 mmol) of (isopropoxycarbonyl)-(S) -cyclohexylalaninal was added to 1.0 m of methylene chloride.
Dissolve in l, acetic anhydride 0.12 ml (1.3 mmol), 4-dimethylaminopyridine 0.5 mg (0.004 mmol), N-benzylquinidinium chloride 9.2 mg (0.02 mmol), water 0.75 ml and 5M sodium cyanide aqueous solution 0.25 ml (1.3 mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 3 hours. Treated as in Example 1, colorless oily (2R, 3S) -2-acetoxy-4
-Cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its mixture with (2S, 3S) -form 7
4.2 mg (57%: N- (isopropoxycarbonyl)-
(Total yield from (S) -cyclohexylalaninol)
I got The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was determined to be 7: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例5 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.0mg(0.10mmol)を塩化メチレン1.5m
lに溶解し、無水酢酸0.035ml(0.37mmol)、ピリジン0.
03mg(0.37mmol)、塩化ベンジルトリブチルアンモニウ
ム1.9mg(0.006mmol)、0.25Mシアン化ナトリウム水溶
液1.5ml(0.38mmol)を氷冷下順次加え、同温度で1.5時
間攪拌した。実施例1と同様に処理し、無色オイル状の
(2R,3S)−2−アセトキシ−4−シクロヘキシル−3
−イソプロポキシカルボニルアミノブチロニトリルおよ
びその(2S,3S)−体との混合物18.6mg(49%:N−(イ
ソプロポキシカルボニル)−(S)−シクロヘキシルア
ラニノールからの通算収率)を得た。(2R,3S)−体と
(2S,3S)−体との生成比は実施例1と同様にNMRスペク
トル(400MHz)から6:1と決定した。
Example 5 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol N-obtained from 30.0 mg (0.12 mmol)
(Isopropoxycarbonyl)-(S) -cyclohexylalaninal 25.0 mg (0.10 mmol) was added to methylene chloride 1.5 m.
Dissolve in l, acetic anhydride 0.035 ml (0.37 mmol), pyridine 0.
03 mg (0.37 mmol), benzyltributylammonium chloride 1.9 mg (0.006 mmol), and 0.25 M sodium cyanide aqueous solution 1.5 ml (0.38 mmol) were sequentially added under ice cooling, and the mixture was stirred at the same temperature for 1.5 hours. The same treatment as in Example 1 was carried out to give colorless oily (2R, 3S) -2-acetoxy-4-cyclohexyl-3.
18.6 mg (49%: total yield from N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol) of isopropoxycarbonylaminobutyronitrile and its mixture with the (2S, 3S) -form were obtained. . The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was determined to be 6: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例6〜24 実施例6〜24について実施例3と同様に行い下記の結
果を得た。カルボン酸無水物としてはすべて無水酢酸3.
6当量を用いて行った。また、収率はN−(イソプロポ
キシカルボニル)−(S)−シクロヘキシルアラニノー
ルからの通算収率であり、(2R,3S)−体と(2S,3S)−
体との生成比はNMRスペクトル(400MHz)から決定し
た。
Examples 6 to 24 Examples 6 to 24 were performed in the same manner as in Example 3 and the following results were obtained. All carboxylic acid anhydrides are acetic anhydride 3.
Performed using 6 equivalents. In addition, the yield is the total yield from N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol, which is the (2R, 3S) -form and the (2S, 3S) -form.
The production ratio with the body was determined from the NMR spectrum (400 MHz).

実施例25 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.0mg(0.10mmol)を塩化メチレン1.5m
lに溶解し、無水安息香酸0.07ml(0.37mmol)、4−ジ
メチルアミノピリジン0.15mg(0.0012mmol)、塩化ベン
ジルトリブチルアンモニウム2.0mg(0.0066mmol)、0.2
5Mシアン化ナトリウム水溶液1.5ml(0.38mmol)を氷冷
下順次加え、同温度で1.5時間攪拌した。実施例1と同
様に処理して得た残渣を薄層クロマトグラフィー(シリ
カゲル、ヘキサン−酢酸エチル3:1)で精製し、無色オ
イル状の(2R,3S)−2−ベンゾキシ−4−シクロヘキ
シル−3−イソプロポキシカルボニルアミノブチロニト
リルとその(2S,3S)−体との混合物27.2mg(59%:N−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニノールからの通算収率)を得た。(2R,3S)−
体と(2S,3S)−体との生成比はNMRスペクトル(400MH
z)から5:1と決定した。
Example 25 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol N-obtained from 30.0 mg (0.12 mmol)
(Isopropoxycarbonyl)-(S) -cyclohexylalaninal 25.0 mg (0.10 mmol) was added to methylene chloride 1.5 m.
Dissolve in l, benzoic anhydride 0.07 ml (0.37 mmol), 4-dimethylaminopyridine 0.15 mg (0.0012 mmol), benzyltributylammonium chloride 2.0 mg (0.0066 mmol), 0.2
1.5M aqueous solution of 5M sodium cyanide (0.38mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 1.5 hours. The residue obtained by treating in the same manner as in Example 1 was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 3: 1), and colorless oily (2R, 3S) -2-benzoxy-4-cyclohexyl- A mixture of 3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form 27.2 mg (59%: N-
(Isopropoxycarbonyl)-(S) -cyclohexylalaninol was obtained. (2R, 3S)-
The ratio of the (2S, 3S) -form to the NMR spectrum (400MH
z) was determined to be 5: 1.

Rf:0.69(ヘキサン/酢酸エチル=7/3) IR(neat):1735,1720,1690cm-1 NMR(CDCl3) (2R,3S)−体;δ0.82〜1.94(19H,m),4.10〜4.46(1
H,m),4.57〜4.76(1H,m),4.82〜5.10(1H,m),5.64
(1H,d,J=5.0Hz),7.40〜7.75(3H,m),8.00〜8.16(2
H,m) (2S,3S)−体;δ0.82〜1.94(19H,m),4.10〜4.46(1
H,m),4.57〜4.76(1H,m),4.82〜5.10(1H,m),5.63
(1H,d,J=3.7Hz),7.40〜7.75(3H,m),8.00〜8.16(2
H,m) MS(m/e):313,212 比較例1 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.0mg(0.10mmol)を塩化メチレン1.5m
lに溶解し、塩化ベンジルトリブチルアンモニウム1.9mg
(0.006mmol)、0.25Mシアン化ナトリウム水溶液1.5ml
(0.38mmol)を氷冷下順次加え、同温度で1.5時間攪拌
した。実施例1と同様に処理し、粗製の(2R,3S)−4
−シクロヘキシル−2−ヒドロキシ−3−イソプロポキ
シルカルボニルアミノブチロニトリルおよびその(2S,3
S)−体との混合物を得た。この混合物に無水酢酸0.25m
l、触媒量の4−ジメチルアミノピリジン、ピリジン0.5
mlを加え、室温で2時間攪拌した。反応液に1M塩酸塩を
加え、エーテルで抽出し、抽出液を飽和食塩水、飽和硫
酸銅水溶液、飽和食塩水、1M水酸化ナトリム水溶液、お
よび飽和食塩水で順次洗浄した。無水硫酸ナトリウム上
で乾燥後、減圧下に濃縮し、残渣をカラムクトロマトグ
ラフィー(シリカゲル、ヘキサン−酢酸エチル30:1→1
0:1)で精製し、無色オイル状の(2R,3S)−2−アセト
キシ−4−シクロヘキシル−3−イソプロポキシカルボ
ニルアミノブチロニトリルおよびその(2S,3S)−体と
の混合物20.0mg(52%:N−(イソプロポキシカルボニ
ル)−(S)−シクロヘキシルアラニノールからの通算
収率)を得た。(2R,3S)−体と(2S,3S)−体との生成
比は実施例1と同様にNMRスペクトル(400MHz)から1:1
と決定した。
Rf: 0.69 (hexane / ethyl acetate = 7/3) IR (neat): 1735, 1720, 1690 cm -1 NMR (CDCl 3 ) (2R, 3S) -form; δ 0.82 to 1.94 (19H, m), 4.10 ~ 4.46 (1
H, m), 4.57 to 4.76 (1H, m), 4.82 to 5.10 (1H, m), 5.64
(1H, d, J = 5.0Hz), 7.40 to 7.75 (3H, m), 8.00 to 8.16 (2
H, m) (2S, 3S) -body; δ 0.82 to 1.94 (19H, m), 4.10 to 4.46 (1
H, m), 4.57 to 4.76 (1H, m), 4.82 to 5.10 (1H, m), 5.63
(1H, d, J = 3.7Hz), 7.40 to 7.75 (3H, m), 8.00 to 8.16 (2
H, m) MS (m / e): 313,212 Comparative Example 1 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol N-obtained from 30.0 mg (0.12 mmol)
(Isopropoxycarbonyl)-(S) -cyclohexylalaninal 25.0 mg (0.10 mmol) was added to methylene chloride 1.5 m.
dissolved in l, benzyltributylammonium chloride 1.9mg
(0.006mmol), 0.25M sodium cyanide aqueous solution 1.5ml
(0.38 mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 1.5 hours. Treated as in Example 1 to give crude (2R, 3S) -4.
-Cyclohexyl-2-hydroxy-3-isopropoxyl carbonylaminobutyronitrile and its (2S, 3
A mixture with S) -form was obtained. 0.25m acetic anhydride to this mixture
l, catalytic amount of 4-dimethylaminopyridine, pyridine 0.5
ml was added, and the mixture was stirred at room temperature for 2 hours. 1M Hydrochloride was added to the reaction solution, which was extracted with ether. The extract was washed successively with saturated saline, saturated copper sulfate aqueous solution, saturated saline, 1M sodium hydroxide aqueous solution, and saturated saline. After drying over anhydrous sodium sulfate, it was concentrated under reduced pressure, and the residue was subjected to column chromatography (silica gel, hexane-ethyl acetate 30: 1 → 1).
2: 1 mg of a colorless oily mixture of (2R, 3S) -2-acetoxy-4-cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form. 52%: N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol total yield) was obtained. The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was 1: 1 from the NMR spectrum (400 MHz) as in Example 1.
I decided.

比較例2 N−(イソプロポキシカルボニル)−(S)−シクロ
ヘキシルアラニノール30.0mg(0.12mmol)より得たN−
(イソプロポキシカルボニル)−(S)−シクロヘキシ
ルアラニナール25.4mg(0.11mmol)を塩化メチレン1.5m
lに溶解し、氷冷下0.25Nシアン化ナトリウム水溶液1.5m
l(0.38mmol)を加え、同温度で1.5時間攪拌した。実施
例1と同様に処理し、粗製の(2R,3S)−4−シクロヘ
キシル−2−ヒドロキシ−3−イソプロポキシルカルボ
ニルアミノブチロニトリルおよびその(2S,3S)−体と
の混合物を得た。この混合物に無水酢酸0.25ml、ピリジ
ン0.5ml、触媒量の4−ジメチルアミノピリジンを加
え、室温で3時間攪拌した。比較例1と同様に処理し、
無色オイル状の(2R,3S)−2−アセトキシ−4−シク
ロヘキシル−3−イソプロポキシカルボニルアミノブチ
ロニトリルおよびその(2S,3S)−体との混合物20.2mg
(53%:N−(イソプロポキシカルボニル)−(S)−シ
クロヘキシルアラニノールからの通算収率)を得た。
(2R,3S)−体と(2S,3S)−体との生成比は実施例1と
同様にNMRスペクトル(400MHz)から1:1と決定した。
Comparative Example 2 N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol obtained from 30.0 mg (0.12 mmol) of N-
25.4 mg (0.11 mmol) of (isopropoxycarbonyl)-(S) -cyclohexylalaninal was added to 1.5 m of methylene chloride.
Dissolve in l, 0.25N sodium cyanide aqueous solution 1.5m under ice cooling
l (0.38 mmol) was added, and the mixture was stirred at the same temperature for 1.5 hours. Treatment as in Example 1 gave crude (2R, 3S) -4-cyclohexyl-2-hydroxy-3-isopropoxylcarbonylaminobutyronitrile and its mixture with (2S, 3S) -form. . To this mixture were added acetic anhydride 0.25 ml, pyridine 0.5 ml, and a catalytic amount of 4-dimethylaminopyridine, and the mixture was stirred at room temperature for 3 hours. Treated as in Comparative Example 1,
Colorless oily (2R, 3S) -2-acetoxy-4-cyclohexyl-3-isopropoxycarbonylaminobutyronitrile and its mixture with (2S, 3S) -form 20.2 mg
(53%: N- (isopropoxycarbonyl)-(S) -cyclohexylalaninol total yield) was obtained.
The production ratio of the (2R, 3S) -form and the (2S, 3S) -form was determined to be 1: 1 from the NMR spectrum (400 MHz) as in Example 1.

参考例5 (2R,3S)−2−アセトキシ−4−シクロヘキシル−
3−イソプロポキシカルボニルアミノブチロニトリルと
その(2S,3S)−体との6:1混合物392mg(1.3mmol)を酢
酸エチル20mlに溶解し、水5ml、濃塩酸13mlを加え反応
液を100℃に加熱して酢酸エチルを留去した。さらに濃
塩酸5mlを加え80℃で9時間加熱攪拌した。反応液を減
圧下約1〜2mlまで濃縮し、一晩放置後析出結晶をろ取
した。トルエンで洗浄後、減圧下に乾燥し、白色結晶の
(2R,3S)−3−アミノ−4−シクロヘキシル−2−ヒ
ドロキシ酪酸塩酸塩111mg(37%)を得た。
Reference Example 5 (2R, 3S) -2-acetoxy-4-cyclohexyl-
392 mg (1.3 mmol) of a 6: 1 mixture of 3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form was dissolved in 20 ml of ethyl acetate, 5 ml of water and 13 ml of concentrated hydrochloric acid were added, and the reaction mixture was heated to 100 ° C. The mixture was heated to and ethyl acetate was distilled off. Further, 5 ml of concentrated hydrochloric acid was added, and the mixture was heated with stirring at 80 ° C. for 9 hours. The reaction solution was concentrated under reduced pressure to about 1 to 2 ml, allowed to stand overnight, and the precipitated crystals were collected by filtration. After washing with toluene, it was dried under reduced pressure to obtain 111 mg (37%) of white crystals of (2R, 3S) -3-amino-4-cyclohexyl-2-hydroxybutyric acid hydrochloride.

融 点:190℃ ▲〔α〕20 D▼:−12.4°(C=0.482,1NHCl) −12.2°(C=2.045,H2O) IR(KBr):1725cm-1 NMR(D2O) δ:0.86〜1.78(13H,m),3.70(1H,dt,J=7.2,3.5Hz),
4.36(1H,d,J=3.5Hz) MS(m/e):202([MH-HCl]+),156,126,104 参考例6 (2R,3S)−2−アセトキシ−4−シクロヘキシル−
3−イソプロポキシカルボニルアミノブチロニトリルと
その(2S,3S)−体との6:1混合物21.6mg(0.070mmol)
を参考例5と同様に加水分解した後、反応液を減圧下に
濃縮乾固し、粗製の(2R,3S)−3−アミノ−4−シク
ロヘキシル−2−ヒドロキシ酪酸塩酸塩とその(2S,3
S)−体との6:1混合物19.3mgを定量的に得た。
Melting point: 190 ° C ▲ [α] 20 D ▼: -12.4 ° (C = 0.482, 1NHCl) -12.2 ° (C = 2.045, H 2 O) IR (KBr): 1725cm -1 NMR (D 2 O) δ : 0.86 to 1.78 (13H, m), 3.70 (1H, dt, J = 7.2,3.5Hz),
4.36 (1H, d, J = 3.5Hz) MS (m / e): 202 ([MH-HCl] + ), 156,126,104 Reference Example 6 (2R, 3S) -2-acetoxy-4-cyclohexyl-
21.6 mg (0.070 mmol) of a 6: 1 mixture of 3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form
Was hydrolyzed in the same manner as in Reference Example 5, the reaction solution was concentrated to dryness under reduced pressure, and crude (2R, 3S) -3-amino-4-cyclohexyl-2-hydroxybutyric acid hydrochloride and its (2S, 3
19.3 mg of a 6: 1 mixture with the S) -form was quantitatively obtained.

NMR(D2O) (2R,3S)−体;δ:0.86〜1.78(13H,m),3.70(1H,dt,
J=7.2,3.5Hz),4.36(1H,d,J=3.5Hz) (2S,3S)−体;δ:0.86〜1.78(13H,m),3.76〜3.84
(1H,m),4.48(1H,d,J=3.2Hz) 参考例7 (2R,3S)−2−ベンゾキシ−4−シクロヘキシル−
3−イソプロポキシカルボニルアミノブチロニトリルと
その(2S,3S)−体との5:1混合物13.6mg(0.037mmol)
を酢酸エチル1mlに溶解し、水1ml、濃塩酸1mlを加え反
応液を100℃に加熱して酢酸エチルを留去した。さらに
濃塩酸0.5mlを加え、80℃で10時間加熱攪拌した。反応
液を減圧下に濃縮乾固し、(2R,3S)−3−アミノ−4
−シクロヘキシル−2−ヒドロキシ酪酸塩酸塩とその
(2S,3S)−体との5:1混合物10.4mgを定量的に得た。
NMR (D 2 O) (2R, 3S) -form; δ: 0.86 to 1.78 (13H, m), 3.70 (1H, dt,
J = 7.2,3.5Hz), 4.36 (1H, d, J = 3.5Hz) (2S, 3S) -body; δ: 0.86 to 1.78 (13H, m), 3.76 to 3.84
(1H, m), 4.48 (1H, d, J = 3.2Hz) Reference Example 7 (2R, 3S) -2-Benzoxy-4-cyclohexyl-
13.6 mg (0.037 mmol) of a 5: 1 mixture of 3-isopropoxycarbonylaminobutyronitrile and its (2S, 3S) -form
Was dissolved in 1 ml of ethyl acetate, 1 ml of water and 1 ml of concentrated hydrochloric acid were added, and the reaction solution was heated to 100 ° C. to distill off ethyl acetate. Furthermore, 0.5 ml of concentrated hydrochloric acid was added, and the mixture was heated with stirring at 80 ° C. for 10 hours. The reaction solution was concentrated to dryness under reduced pressure, and (2R, 3S) -3-amino-4
10.4 mg of a 5: 1 mixture of cyclohexyl-2-hydroxybutyric acid hydrochloride and its (2S, 3S) -form were quantitatively obtained.

このもののNMRスペクトルは参考例6に記載したもの
にほぼ一致した。
The NMR spectrum of this product was almost the same as that described in Reference Example 6.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 酒井 邦和 東京都杉並区浜田山4―19―11 (72)発明者 常本 大英 神奈川県座間市緑ケ丘2―24―5 (72)発明者 上條 哲聖 長野県塩尻市大字広丘吉田2525番地 (72)発明者 原田 弘 長野県東筑摩郡四賀村大字中川8054番地 審査官 今村 玲英子 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Kunikazu Sakai 4-19-11 Hamadayama, Suginami-ku, Tokyo (72) Inventor Daisuke Tsunemoto 2-24-5 Midorigaoka, Zama City, Kanagawa Prefecture (72) Inventor Satoshi Kamijo 2525 Hirooka, Yoshida, Ojira, Shiojiri City, Nagano Prefecture (72) Inventor Hiroshi Harada 8054, Nakagawa, Shiga-mura, Higashichikuma-gun, Nagano Examiner Reiko Imamura

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中、R1は炭素数1〜4の直鎖若しくは分枝アルキル
基、炭素数5〜8のシクロアルキル基を表し、R2は炭素
数1〜4の直鎖あるいは分枝アルカノイル基、塩素原子
若しくはメトキシ基で置換されていてもよいアロイル
基、炭素数1〜5の直鎖あるいは分枝アルコキシカルボ
ニル基、または塩素原子若しくはメトキシ基で置換され
ていてもよいアラルコキシカルボニル基を表し、R3は水
素原子、炭素数1〜4の直鎖若しくは分枝アルキル基ま
たは塩素原子若しくはメトキシ基で置換されていてもよ
いアリール基を表す)で表される3−アミノ−2−アシ
ルオキシ−ブチロニトリル誘導体。
1. A general formula (In the formula, R 1 represents a linear or branched alkyl group having 1 to 4 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, R 2 represents a linear or branched alkanoyl group having 1 to 4 carbon atoms, Represents an aroyl group optionally substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms, or an aralkoxycarbonyl group optionally substituted with a chlorine atom or a methoxy group. , R 3 represents a hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms, or a chlorine atom or an aryl group which may be substituted with a methoxy group). Butyronitrile derivative.
【請求項2】2位不斉炭素が(R)−配置、3位不斉炭
素が(S)−配置である請求項(1)記載の化合物。
2. The compound according to claim 1, wherein the 2-position asymmetric carbon has (R) -configuration and the 3-position asymmetric carbon has (S) -configuration.
【請求項3】R1がシクロヘキシル基である請求項(2)
記載の化合物。
3. The method according to claim 2, wherein R 1 is a cyclohexyl group.
A compound as described.
【請求項4】一般式 (式中、R1は炭素数1〜4の直鎖若しくは分枝アルキル
基、炭素数5〜8のシクロアルキル基を表し、またR2
炭素数1〜4の直鎖あるいは分枝アルカノイル基、塩素
原子若しくはメトキシ基で置換されていてもよいアロイ
ル基、炭素数1〜5の直鎖あるいは分枝アルコキシカル
ボニル基、または塩素原子若しくはメトキシ基で置換さ
れていてもよいアラルコキシカルボニル基を表す)で表
される2−アミノアルデヒド誘導体を、一般式 R3COOCOR4 (式中、R3、R4は各々独立に、水素原子、炭素数1〜4
の直鎖若しくは分枝アルキル基または塩素原子若しくは
メトキシ基で置換されていてもよいアリール基を表す)
で表されるカルボン酸無水物および青酸塩と第四級アン
モニウム塩および/または第三級アミンの存在下反応さ
せることを特徴とする、一般式 (式中、R1、R2およびR3は前記と同じ意味を表す)で表
される3−アミノ−2−アシルオキシ−ブチロニトリル
誘導体の製造方法。
4. A general formula (In the formula, R 1 represents a linear or branched alkyl group having 1 to 4 carbon atoms or a cycloalkyl group having 5 to 8 carbon atoms, and R 2 represents a linear or branched alkanoyl group having 1 to 4 carbon atoms. , An aroyl group which may be substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms, or an aralkoxycarbonyl group which may be substituted with a chlorine atom or a methoxy group. Represented by the general formula R 3 COOCOR 4 (wherein R 3 and R 4 are each independently a hydrogen atom or a carbon number of 1 to 4).
Represents a linear or branched alkyl group, or an aryl group which may be substituted with a chlorine atom or a methoxy group)
A general formula characterized by reacting a carboxylic acid anhydride and hydrocyanic acid salt represented by the following in the presence of a quaternary ammonium salt and / or a tertiary amine: (In the formula, R 1 , R 2 and R 3 have the same meanings as described above.) A method for producing a 3-amino-2-acyloxy-butyronitrile derivative.
【請求項5】2位不斉炭素が(R)−配置、3位不斉炭
素が(S)−配置である請求項(4)記載の3−アミノ
−2−アシルオキシ−ブチロニトリル誘導体の製造方
法。
5. The method for producing a 3-amino-2-acyloxy-butyronitrile derivative according to claim 4, wherein the 2-position asymmetric carbon has (R) -configuration and the 3-position asymmetric carbon has (S) -configuration. .
【請求項6】R1がシクロヘキシル基である請求項(5)
記載の3−アミノ−2−アシルオキシ−ブチロニトリル
誘導体の製造方法。
6. The method according to claim 5, wherein R 1 is a cyclohexyl group.
A method for producing the described 3-amino-2-acyloxy-butyronitrile derivative.
JP63206940A 1988-08-19 1988-08-19 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same Expired - Lifetime JPH0819071B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63206940A JPH0819071B2 (en) 1988-08-19 1988-08-19 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63206940A JPH0819071B2 (en) 1988-08-19 1988-08-19 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0256457A JPH0256457A (en) 1990-02-26
JPH0819071B2 true JPH0819071B2 (en) 1996-02-28

Family

ID=16531556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63206940A Expired - Lifetime JPH0819071B2 (en) 1988-08-19 1988-08-19 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0819071B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2959397A (en) * 1996-05-31 1998-01-05 Novartis Ag Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues
JP4780437B2 (en) * 2004-12-08 2011-09-28 大原薬品工業株式会社 Process for producing 2-oxoimidazolidine derivatives

Also Published As

Publication number Publication date
JPH0256457A (en) 1990-02-26

Similar Documents

Publication Publication Date Title
JP2611244B2 (en) Method for producing thiazolidinedione derivative
IE62804B1 (en) Novel process for the manufacture of 4-acyloxy-3-hydroxyethyl-azetidinones
JP2691442B2 (en) Novel proline derivative
JPH06172256A (en) Production of 3-hydroxybutyric acid derivative
JPH0819071B2 (en) 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same
EP1063232B1 (en) Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
Boyd et al. Stereoselective syntheses of hydroxyethylene dipeptide isosteres
EP0934923B1 (en) Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters
JPH0819072B2 (en) (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same
KR0163770B1 (en) Process for the production of 3,4-epoxybutyrate and intermediate thereof
JPS60199884A (en) Novel preparation of bestatin and its intermediate
EP1362845B1 (en) New process for the synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and their use in the synthesis of perindopril
JPH0830049B2 (en) Process for producing 4-amino-3-hydroxypentanoic acid derivative
KR950009364B1 (en) Process for preparing optical active 2-oxoimidazolodone derivatives
JPH0780839B2 (en) Method for producing azetidinones
JPH07165678A (en) Nitroolefin compound
US5959141A (en) 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
US4088644A (en) N-Acyl-3-azetidinone
JPH0259545A (en) 3-amino-2-hydroxy-1-nitrobutane derivative and production of alpha-hydroxy-beta-amino acid
JPH0745501B2 (en) Novel cyclic dipeptide compound
JP3864672B2 (en) Method for producing erythro-3-amino-2-hydroxybutyric acid derivative
JPH10175944A (en) Production of cystacyclin and its intermediate
JPH0812658A (en) Production of sydnones
JP2005298337A (en) METHOD FOR PRODUCING beta-HYDROXYAMINO ACID DERIVATIVE AND INTERMEDIATE OF THE SAME
JPH0269465A (en) Production of optically active n-acylhistidine derivative